Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination | Science
Use of Tissue Cross-reactivity Studies in the Development of Antibody-based Biopharmaceuticals: History, Experience, Methodology, and Future Directions - Michael W. Leach, Wendy G. Halpern, Carol W. Johnson, Jennifer L. Rojko, Tim K.
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
Repurposing Old Antibodies for New Diseases by Exploiting Cross-Reactivity and Multicolored Nanoparticles | ACS Nano
Cross‐reactivity in allergy: A double‐edged sword - Pomés - 2020 - Allergy - Wiley Online Library
Frontiers | Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19 - ScienceDirect
Minimizing antibody cross-reactivity in multiplex detection of biomarkers in paper-based point-of-care assays - Nanoscale (RSC Publishing)
Frontiers | Cross-Reactive Immunity Among Flaviviruses
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial - The Lancet
Cross-reactive anti-CCD antibodies can hinder allergy diagnostics - EUROIMMUNBlog
Sero-Prevalence and Cross-Reactivity of Chikungunya Virus Specific Anti-E2EP3 Antibodies in Arbovirus-Infected Patients | PLOS Neglected Tropical Diseases
HIV-1 Envelope gp41 Antibodies Can Originate from Terminal Ileum B Cells that Share Cross-Reactivity with Commensal Bacteria - ScienceDirect
A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells | EMBO Molecular Medicine
Figure 2 - Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection - Volume 23, Number 5—May 2017 - Emerging Infectious Diseases journal - CDC
ELISA Kit Quality Assurance: cross reaction | Sino Biological
Frontiers | Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development
Cells | Free Full-Text | Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens
42.13: Antibodies - Antibody Functions - Biology LibreTexts
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age | PNAS
Interferences in quantitative immunochemical methods - Biochemia Medica
Cross-reactivity of Antibody: Beneficial or Harmful? - Cusabio
Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay | eLife
Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | SpringerLink
Frontiers | Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases
